Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Income: 2020-2025

Historic Net Income for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to -$166.0 million.

  • Roivant Sciences' Net Income fell 285.39% to -$166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.0 million, marking a year-over-year decrease of 64.01%. This contributed to the annual value of $373.2 million for FY2025, which is 218.42% up from last year.
  • Per Roivant Sciences' latest filing, its Net Income stood at -$166.0 million for Q3 2025, which was up 39.38% from -$273.9 million recorded in Q2 2025.
  • Roivant Sciences' Net Income's 5-year high stood at $327.0 million during Q4 2024, with a 5-year trough of -$384.9 million in Q4 2022.
  • Over the past 3 years, Roivant Sciences' median Net Income value was -$70.6 million (recorded in 2023), while the average stood at -$67.0 million.
  • Per our database at Business Quant, Roivant Sciences' Net Income tumbled by 1,167.12% in 2021 and then surged by 658.87% in 2024.
  • Quarterly analysis of 5 years shows Roivant Sciences' Net Income stood at -$306.1 million in 2021, then fell by 25.75% to -$384.9 million in 2022, then surged by 84.80% to -$58.5 million in 2023, then spiked by 658.87% to $327.0 million in 2024, then slumped by 285.39% to -$166.0 million in 2025.
  • Its Net Income was -$166.0 million in Q3 2025, compared to -$273.9 million in Q2 2025 and $327.0 million in Q4 2024.